文献速递关节外科

体重指数与全髋和全膝关节置换术后全因死亡率相关

Body Mass Index Is Associated With All-cause Mortality After THA and TKA.
PubMed 文献 · Clin Orthop Relat Res · 2018-01-01

研究利用澳大利亚SMART登记处和美国KPTJRR登记处2002年至2013年数据,分析≥18岁择期全髋和全膝关节置换患者体重指数(BMI)与全因死亡率的关系。结果显示,在两个队列中,体重过低与全膝关节置换术后全因死亡率升高相关,而肥胖I级或II级与死亡率降低相关;在美国队列中,全髋关节置换术后体重过低与死亡率升高相关,超重、肥胖I级或II级与死亡率降低相关,但澳大利亚队列全髋关节置换术后BMI与死亡风险无关。作者认为即使严重肥胖也不与关节置换术后死亡风险升高相关,并建议在考虑全关节置换术时对体重过低患者谨慎评估其营养状况。

要点

  • 在澳大利亚和美国队列中,体重过低与全膝关节置换术后全因死亡率升高相关(澳大利亚HR 3.72,美国HR 1.88)。
  • 在美国队列中,体重过低与全髋关节置换术后全因死亡率升高相关(HR 2.09),而超重、肥胖I级或II级与死亡率降低相关。
  • 在澳大利亚队列中,全髋关节置换术后BMI与死亡风险无关;作者建议对体重过低患者考虑全关节置换术前谨慎评估营养状况。

核心结论

  • 即使严重肥胖也不与关节置换术后死亡风险升高相关,应告知患者在考虑手术时了解这一点。
  • 临床医生在考虑对体重过低患者行全关节置换术时,应谨慎并首先考虑其营养状况。

研究设计与样本

  • 研究使用澳大利亚St Vincent's Melbourne Arthroplasty(SMART)登记处和美国Kaiser Permanente Total Joint Replacement Registry(KPTJRR)登记处的数据,纳入2002年1月1日至2013年12月31日期间接受择期全膝关节置换和全髋关节置换的≥18岁患者。
  • 排除同日双侧全髋关节置换和半髋关节置换;从手术当天至研究结束(2013年12月31日)记录全因死亡率。
  • SMART登记处数据采集完整;KPTJRR队列无患者失访,有2959例(5%)全髋关节置换和5251例(5%)全膝关节置换存在缺失数据。
  • 采用Cox比例风险回归估计六类BMI与全因死亡率的关联:体重过低(<18.5 kg/m²)、正常体重(18.5-24.9 kg/m²)、超重(25.0-29.9 kg/m²)、肥胖I级(30.0-34.9 kg/m²)、肥胖II级(35.0-39.9 kg/m²)、肥胖III级(>40 kg/m²)。
  • 全膝关节置换中,SMART队列中位随访5年(范围0-12年),KPTJRR队列中位随访4年(范围0-12年);全髋关节置换中,SMART队列中位随访5年(范围0-12年),KPTJRR队列中位随访4年(范围0-12年)。

主要发现

  • 在澳大利亚和美国队列中,体重过低与全膝关节置换术后全因死亡率升高相关(澳大利亚:HR 3.72,95%CI 1.94-7.08,p<0.001;美国:HR 1.88,95%CI 1.33-2.64,p<0.001)。
  • 与正常体重患者相比,肥胖I级(澳大利亚:HR 0.66,95%CI 0.47-0.92,p=0.015;美国:HR 0.71,95%CI 0.66-0.78,p<0.001)或肥胖II级(澳大利亚:HR 0.54,95%CI 0.35-0.82,p=0.004;美国:HR 0.73,95%CI 0.66-0.81,p<0.001)与全膝关节置换术后死亡率降低相关。
  • 在美国队列中,超重也与全膝关节置换术后死亡风险降低相关(HR 0.76,95%CI 0.71-0.82,p<0.001)。
  • 在美国队列中,体重过低与全髋关节置换术后死亡风险升高相关(HR 2.09,95%CI 1.65-2.64,p<0.001),而超重(HR 0.73,95%CI 0.67-0.80,p<0.001)、肥胖I级(HR 0.68,95%CI 0.62-0.75,p<0.001)或肥胖II级(HR 0.71,95%CI 0.62-0.81,p<0.001)与全髋关节置换术后死亡风险降低相关。
  • 在澳大利亚队列接受全髋关节置换的患者中,未观察到BMI与死亡风险之间的关联。

关键数值与推荐

  • BMI分类阈值:体重过低<18.5 kg/m²,正常体重18.5-24.9 kg/m²,超重25.0-29.9 kg/m²,肥胖I级30.0-34.9 kg/m²,肥胖II级35.0-39.9 kg/m²,肥胖III级>40 kg/m²。
  • 全膝关节置换术后全因死亡率:体重过低澳大利亚HR 3.72(95%CI 1.94-7.08,p<0.001)、美国HR 1.88(95%CI 1.33-2.64,p<0.001);肥胖I级澳大利亚HR 0.66(95%CI 0.47-0.92,p=0.015)、美国HR 0.71(95%CI 0.66-0.78,p<0.001);肥胖II级澳大利亚HR 0.54(95%CI 0.35-0.82,p=0.004)、美国HR 0.73(95%CI 0.66-0.81,p<0.001);美国超重HR 0.76(95%CI 0.71-0.82,p<0.001)。
  • 全髋关节置换术后全因死亡率(美国队列):体重过低HR 2.09(95%CI 1.65-2.64,p<0.001);超重HR 0.73(95%CI 0.67-0.80,p<0.001);肥胖I级HR 0.68(95%CI 0.62-0.75,p<0.001);肥胖II级HR 0.71(95%CI 0.62-0.81,p<0.001)。
  • 澳大利亚队列全髋关节置换术后BMI与死亡风险无关联。

临床怎么用

  • 作者认为,应告知患者在考虑关节置换术时,即使严重肥胖也不与术后死亡风险升高相关。
  • 作者建议,临床医生在考虑对体重过低患者行全关节置换术时,应谨慎并首先考虑其营养状况。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Both obesity and underweight are associated with a higher risk of mortality in adulthood, but the association between mortality after arthroplasty and extreme ranges of body mass index (BMI) have not been evaluated beyond the first year. QUESTIONS/PURPOSES: The purpose of this study was to investigate the association between BMI and all-cause mortality after TKA and THA. METHODS: Data from two arthroplasty registries, the St Vincent's Melbourne Arthroplasty (SMART) Registry from Australia and the Kaiser Permanente Total Joint Replacement Registry (KPTJRR) from the United States, were used to identify patients aged ≥ 18 years undergoing elective TKAs and THAs between January 1, 2002, and December 31, 2013. Same-day bilateral THA and hemiarthroplasties were excluded. All-cause mortality was recorded from the day of surgery to the end of the study (December 31, 2013). Data capture was complete for the SMART Registry. No patients were lost to followup in the KPTJRR cohort and 2959 (5%) THAs and 5251 (5%) TKAs had missing data. Cox proportional hazard regression was used to estimate the all-cause mortality associated with six BMI categories: underweight (< 18.5 kg/m), normal weight (18.5-24.9 kg/m), overweight (25.0-29.9 kg/m), obese class I (30.0-34.9 kg/m), obese class II (35.0-39.9 kg/m), and obese class III (> 40 kg/m). For TKA, the SMART cohort had a median followup of 5 years (range, 0-12 years) and the KPTJRR cohort had a median followup of 4 years (range, 0-12 years). For THA, the SMART cohort had a median followup of 5 years (range, 0-12 years) and the KPTJRR cohort had a median followup of 4 years (range, 0-12 years). RESULTS: In both the Australian and US cohorts, being underweight (Australia: hazard ratio [HR], 3.72; 95% confidence interval [CI], 1.94-7.08; p < 0.001 and United States: HR, 1.88; 95% CI, 1.33-2.64; p < 0.001) was associated with higher all-cause mortality after TKA, whereas obese class I (Australia: HR, 0.66; 95% CI, 0.47-0.92; p = 0.015; United States: HR, 0.71; 95% CI, 0.66-0.78; p < 0.001) or obese class II (Australia: HR, 0.54; 95% CI, 0.35-0.82; p = 0.004; United States: HR, 0.73; 95% CI, 0.66-0.81; p < 0.001) was associated with lower mortality when compared with normal-weight patients. In the US cohort, being overweight was also associated with a lower risk of mortality (HR, 0.76; 95% CI, 0.71-0.82; p < 0.001). In the US cohort, being underweight had a higher risk of mortality after THA (HR, 2.09; 95% CI, 1.65-2.64; p < 0.001), whereas those overweight (HR, 0.73; 95% CI, 0.67-0.80; p < 0.001), obese class I (HR, 0.68; 95% CI, 0.62-0.75; p < 0.001), or obese class II (HR, 0.71; 95% CI, 0.62-0.81; p < 0.001) were at a lower risk of mortality after THA when compared with normal-weight patients. In patients undergoing THA in the Australian cohort, we observed no association between BMI and risk of death. CONCLUSIONS: We found that even severe obesity is not associated with a higher risk of death after arthroplasty. Patients should be informed of this when considering surgery. Clinicians should be cautious when considering total joint arthroplasty in underweight patients without first considering their nutritional status. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Dowsey MM, Choong PFM, Paxton EW, et al. Body Mass Index Is Associated With All-cause Mortality After THA and TKA. Clin Orthop Relat Res. 2018. PMID: 29775187. doi:10.1007/s11999.0000000000000108

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。